Grupo de Investigación de Microbiología Aplicada del Instituto de Biotecnología y de Biomedicina de la Universidad Autónoma de Barcelona - IBB-UAB

Project Details

Description

Technology capabilities of the group:
-Design and production of proteins for biotechnological, biomedical and nanotechnological applications.
-Development of functional materials based on functional proteins for applications in drug and vaccine design, diagnostics and targeted therapies.
Group patents with the possibility of being licensed:
- Systems for sustained release of protein drugs, nanoparticles and functional proteins, in cosmetics and therapy (PCT / EP2018 / 069303).
Interest in finding industrial partners for:
- Development of sustained release systems of proteins and nanomaterials for cosmetics and therapy.
Interest in participating as partners in projects:
European and International Projects:
- Production of functional proteins and protein materials. Drug design for targeted protein-based therapies.
Collaboration with industry:
- Production of recombinant proteins in different expression systems.
- Development of protein-based sustained release systems for cosmetics, vaccination, diagnosis and therapy.
AcronymCIBER BBN
StatusActive
Effective start/end date1/01/0931/12/30

Funding

  • Institute of Health Carlos III (ISCIII): €1,718,496.97

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.